DK308586D0 - Dna-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet - Google Patents
Dna-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinetInfo
- Publication number
- DK308586D0 DK308586D0 DK308586A DK308586A DK308586D0 DK 308586 D0 DK308586 D0 DK 308586D0 DK 308586 A DK308586 A DK 308586A DK 308586 A DK308586 A DK 308586A DK 308586 D0 DK308586 D0 DK 308586D0
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- cells transfected
- expression
- recombinant vector
- sequence encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74960085A | 1985-06-27 | 1985-06-27 | |
US74960085 | 1985-06-27 | ||
US06/766,109 US4968626A (en) | 1985-08-15 | 1985-08-15 | DNA sequence coding for protein C |
US76610985 | 1985-08-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK308586D0 true DK308586D0 (da) | 1986-06-27 |
DK308586A DK308586A (da) | 1986-12-28 |
DK175574B1 DK175574B1 (da) | 2004-12-13 |
Family
ID=27115147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198603085A DK175574B1 (da) | 1985-06-27 | 1986-06-27 | DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0215548B2 (da) |
JP (2) | JP2614848B2 (da) |
AT (1) | ATE93272T1 (da) |
CA (1) | CA1341228C (da) |
DE (1) | DE3688900T3 (da) |
DK (1) | DK175574B1 (da) |
NO (1) | NO305660B1 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959318A (en) * | 1985-06-27 | 1990-09-25 | Zymogenetics, Inc. | Expression of protein C |
US5550036A (en) | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
USH1148H (en) | 1987-04-17 | 1993-03-02 | Method of separating activated human protein C | |
JP2799316B2 (ja) * | 1987-06-12 | 1998-09-17 | ヘキスト・マリオン・ルセル株式会社 | 雑種ヒトプロテインcおよびその遺伝子工学的製法 |
US5084274A (en) * | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
US5196322A (en) * | 1987-12-28 | 1993-03-23 | Eli Lilly And Company | Vectors and compounds for expression of zymogen forms of human protein C |
JP2728240B2 (ja) * | 1988-07-26 | 1998-03-18 | ヘキスト薬品工業株式会社 | ヒトプロテインc変異体及びその製造方法 |
CA1332049C (en) * | 1988-10-07 | 1994-09-20 | Eli Lilly And Company | Eukaryotic expression |
JP3045307B2 (ja) * | 1989-08-11 | 2000-05-29 | ザイモジェネティクス,インコーポレイティド | 活性化プロテインcを生成するための細胞培養法 |
JP2774156B2 (ja) * | 1989-09-05 | 1998-07-09 | 帝人株式会社 | ヒトプロテインcおよび/または活性化ヒトプロテインc様活性を有する蛋白 |
JP2774163B2 (ja) * | 1989-11-14 | 1998-07-09 | 帝人株式会社 | ヒトプロテインc様活性を有する蛋白 |
US5358932A (en) * | 1989-12-29 | 1994-10-25 | Zymogenetics, Inc. | Hybrid protein C |
ES2113878T3 (es) * | 1989-12-29 | 1998-05-16 | Zymogenetics Inc | Proteina c hibrida. |
IL97311A0 (en) * | 1990-02-23 | 1992-05-25 | Lilly Co Eli | Vectors and compounds for expression of glycosylation mutants of human protein c |
US5270178A (en) * | 1990-02-23 | 1993-12-14 | Eli Lilly And Company | Vectors and compounds for expression of zymogen forms of human protein C |
AT402263B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz |
JPH08508875A (ja) * | 1992-05-01 | 1996-09-24 | 帝人株式会社 | 蛋白分泌細胞の流加回分培養法 |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
US5561053A (en) * | 1994-08-05 | 1996-10-01 | Genentech, Inc. | Method for selecting high-expressing host cells |
JP2003514545A (ja) * | 1999-11-19 | 2003-04-22 | イーライ・リリー・アンド・カンパニー | プロテインc誘導体 |
AP2007004253A0 (en) * | 2005-05-24 | 2007-12-31 | Avestha Gengraine Tech Pvt Ltd | A process comprising codon optimization for the production of recombinant activated human protein C for the treatment of sepsis |
EP2911579B1 (en) | 2012-10-23 | 2020-12-09 | Koninklijke Philips N.V. | Stress-measuring system |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8327860D0 (en) * | 1983-10-18 | 1983-11-16 | Fujisawa Pharmaceutical Co | Monoclonal antiprotein c antibody |
US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
-
1986
- 1986-06-26 DE DE3688900T patent/DE3688900T3/de not_active Expired - Lifetime
- 1986-06-26 EP EP86304970A patent/EP0215548B2/en not_active Expired - Lifetime
- 1986-06-26 AT AT86304970T patent/ATE93272T1/de not_active IP Right Cessation
- 1986-06-26 CA CA000512483A patent/CA1341228C/en not_active Expired - Fee Related
- 1986-06-27 DK DK198603085A patent/DK175574B1/da not_active IP Right Cessation
- 1986-06-27 NO NO862601A patent/NO305660B1/no not_active IP Right Cessation
- 1986-06-27 JP JP61151303A patent/JP2614848B2/ja not_active Expired - Lifetime
-
1996
- 1996-07-09 JP JP8179612A patent/JP2688407B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO862601L (no) | 1986-12-29 |
JPH09107976A (ja) | 1997-04-28 |
DE3688900T3 (de) | 1998-06-10 |
NO305660B1 (no) | 1999-07-05 |
EP0215548B1 (en) | 1993-08-18 |
EP0215548A1 (en) | 1987-03-25 |
CA1341228C (en) | 2001-05-15 |
DK308586A (da) | 1986-12-28 |
NO862601D0 (no) | 1986-06-27 |
DE3688900D1 (de) | 1993-09-23 |
ATE93272T1 (de) | 1993-09-15 |
DK175574B1 (da) | 2004-12-13 |
DE3688900T2 (de) | 1993-12-09 |
JPS62111690A (ja) | 1987-05-22 |
EP0215548B2 (en) | 1998-01-07 |
JP2614848B2 (ja) | 1997-05-28 |
JP2688407B2 (ja) | 1997-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK308586D0 (da) | Dna-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet | |
NO874495L (no) | Ekspresjon av protein c. | |
DE19675006I2 (de) | Fsh. | |
NO963358L (no) | Vertsvektor-system til anvendelse i genterapi | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
ATE88501T1 (de) | Rekombinante dns-expressionsvektoren. | |
NO179106C (no) | Fremgangsmåte for fremstilling av og ekspresjonssystem som koder for og kan uttrykke et rekombinant proteinkompleks med humanfaktor V111:C-aktivitet | |
DK127786D0 (da) | Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertscellerindeholdende vektorerne | |
ATE391175T1 (de) | Multidrug resistenz gen | |
EP0111814A3 (en) | The cloning and expression of nucleotide sequences encoding bovine growth hormone | |
EP0835661A3 (en) | Human interferon-Beta2A for use as a medicament | |
ES2078243T3 (es) | Mejoras en o relativas a la expresion eucariotica. | |
EP0336383A3 (en) | Novel recombinant human lymphotoxin | |
FI882238A0 (fi) | Foerbaettringar i samband med organiska foereningar | |
EP0282512A4 (en) | STABILIZATION OF MESSENGER RNA IN ANIMAL CELLS. | |
ATA435083A (de) | Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen | |
AU6560886A (en) | DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells | |
ES8700694A1 (es) | Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |